UC Staff Senate election May 2-13

Vote now for your representatives for the 2022-24 term​​​​​​​

The Staff Senate election runs until Friday, May 13, 2022, at 5 p.m.

All UC staff not principally charged with teaching, including part-time and full-time staff, are eligible to vote using their UC credentials.

With 90 candidates running for 35 open positions, take the time to review all candidates as you prepare for voting. Because senators are elected by VP area and as At-Large, staff should consider all candidates in all VP areas when casting up to 35 votes in the election.

“The most important role that Staff Senate plays is to be the voice of staff.” Heidi Pettyjohn, current chair of the UC Staff Senate, went on to emphasize “that voice is most effective when Senate represents the diversity of the identity and talent of our impressive workforce.”

Vote now for representatives for the Senate’s fourth full term.

Staff Senate is an advisory body to the UC President and university administration. With representation among colleges, divisions, and departments, the UC Staff Senate serves the university by promoting, protecting, and representing the interests and perspective of university staff. It additionally serves staff through education and appreciation.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.